M-LIDS, as it currently exists, is made up of Coyote missiles, a 30 mm cannon, a .50 calibre gun ... platform with all capabilities mounted on a Stryker infantry fighting vehicle.
offering protection against anti-tank projectiles of calibers up to 30 mm. This represents a higher protection level than that of Russian transporters. The armament of most Stryker variants is a ...
Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers for an undisclosed amount, the company announced Tuesday. The deal is ...
Shares of Stryker Corp. SYK slid 1.35% to $390.49 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086.37 ...
Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...
NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical (NARI.O), opens new tab, which makes devices that treat patients with ...
Stryker (SYK) confirmed an agreement to purchase Inari Medical (NASDAQ:NARI) for about $4.9 billion. Inari jumped 21% in after hours trading. The medical devices firm will pay $80 a share in cash ...
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of ...
Stryker has agreed to acquire medical technology maker Inari Medical NARI-0.15%decrease; red down pointing triangle in a deal worth $4.9 billion, the companies said Monday. The medical device ...
Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...
Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies have approved the transaction, and it’s expected to close in the ...